Page 57 - IMO-1-1

Innovative Medicines & Omics Antioxidant nanomedicines for therapies

and opportunities for nanomedicine in the management of 100. Yang Q, Jiang H, Wang Y, et al. Plaque macrophage-
atherosclerosis. Nat Rev Drug Discov. 2011;10(11):835-852. targeting nanosystems with cooperative co-regulation
of ROS and TRAF6 for stabilization of atherosclerotic
doi: 10.1038/nrd3578
plaques. Adv Funct Mater. 2023;33:2301053.
90. Chen J, Zhang X, Millican R, et al. Recent advances in
nanomaterials for therapy and diagnosis for atherosclerosis. doi: 10.1002/adfm.202301053
Adv Drug Deliv Rev. 2021;170:142-199. 101. Mizushima N, Komatsu M. Autophagy: Renovation of cells
doi: 10.1016/j.addr.2021.01.005 and tissues. Cell. 2011;147(4):728-741.
91. Chen W, Schilperoort M, Cao Y, Shi J, Tabas I, Tao W. Macrophage- doi: 10.1016/j.cell.2011.10.026
targeted nanomedicine for the diagnosis and treatment of 102. Rabinowitz JD, White E. Autophagy and metabolism.
atherosclerosis. Nat Rev Cardiol. 2022;19(4):228-249. Science. 2010;330(6009):1344-1348.
doi: 10.1038/s41569-021-00629-x doi: 10.1126/science.1193497
92. Maruf A, Wang Y, Yin T, et al. Atherosclerosis treatment with 103. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of
stimuli-responsive nanoagents: Recent advances and future cellular degradation. Science. 2000;290(5497):1717-1721.
perspectives. Adv Healthc Mater. 2019;8(11):e1900036.
doi: 10.1126/science.290.5497.1717
doi: 10.1002/adhm.201900036
104. Guo FX, Wu Q, Li P, et al. The role of the LncRNA-FA2H-2-
93. Lobatto ME, Calcagno C, Millon A, et al. Atherosclerotic MLKL pathway in atherosclerosis by regulation of autophagy
plaque targeting mechanism of long-circulating flux and inflammation through mTOR-dependent signaling.
nanoparticles established by multimodal imaging. ACS Cell Death Differ. 2019;26(9):1670-1687.
Nano. 2015;9(2):1837-1847.
doi: 10.1038/s41418-018-0235-z
doi: 10.1021/nn506750r
105. Bravo-San Pedro JM, Kroemer G, Galluzzi L. Autophagy
94. Smith BR. Nanotherapeutics for cardiovascular disease. Nat and mitophagy in cardiovascular disease. Circ Res.
Rev Cardiol. 2021;18(9):617-618. 2017;120(11):1812-1824.
doi: 10.1038/s41569-021-00594-5 doi: 10.1161/CIRCRESAHA.117.311082
95. Wang Y, Li L, Zhao W, et al. Targeted therapy of 106. Wu Z, Zhou M, Tang X, et al. Carrier-free trehalose-based
atherosclerosis by a broad-spectrum reactive oxygen species nanomotors targeting macrophages in inflammatory plaque for
scavenging nanoparticle with intrinsic anti-inflammatory treatment of atherosclerosis. ACS Nano. 2022;16(3):3808-3820.
activity. ACS Nano. 2018;12(9):8943-8960.
doi: 10.1021/acsnano.1c08391
doi: 10.1021/acsnano.8b02037
107. Segawa K, Nagata S. An apoptotic “eat me” signal:
96. Wang S, Zhang J, Li W, et al. Hyaluronic acid-guided Phosphatidylserine exposure. Trends Cell Biol.
assembly of ceria nanozymes as plaque-targeting ROS 2015;25(11):639-650.
scavengers for anti-atherosclerotic therapy. Carbohydr
Polym. 2022;296:119940. doi: 10.1016/j.tcb.2015.08.003
doi: 10.1016/j.carbpol.2022.119940 108. Wang PG, Xian M, Tang X, et al. Nitric oxide donors:
Chemical activities and biological applications. Chem Rev.
97. Parayath NN, Parikh A, Amiji MM. Repolarization of tumor- 2002;102(4):1091-1134.
associated macrophages in a genetically engineered nonsmall
cell lung cancer model by intraperitoneal administration doi: 10.1021/cr000040l
of hyaluronic acid-based nanoparticles encapsulating 109. Carpenter AW, Schoenfisch MH. Nitric oxide release: Part II.
MicroRNA-125b. Nano Lett. 2018;18(6):3571-3579. Therapeutic applications. Chem Soc Rev. 2012;41(10):3742-3752.
doi: 10.1021/acs.nanolett.8b00689 doi: 10.1039/c2cs15273h
98. Mu D, Li J, Qi Y, et al. Hyaluronic acid-coated polymeric micelles 110. Sciarretta S, Yee D, Nagarajan N, et al. Trehalose-induced
with hydrogen peroxide scavenging to encapsulate statins for activation of autophagy improves cardiac remodeling after
alleviating atherosclerosis. J Nanobiotechnology. 2020;18(1):179. myocardial infarction. J Am Coll Cardiol. 2018;71(18):1999-2010.
doi: 10.1186/s12951-020-00744-w doi: 10.1016/j.jacc.2018.02.066
99. Chen X, Dai C, Hu R, Yu L, Chen Y, Zhang B. Engineering 111. Hu R, Dai C, Dong C, et al. Living macrophage-
ROS-scavenging Prussian blue nanozymes for delivered tetrapod PdH nanoenzyme for targeted
efficient atherosclerosis nanotherapy. J Mater Chem B. atherosclerosis management by ROS scavenging, hydrogen
2023;11(9):1881-1890.
anti-inflammation, and autophagy activation. ACS
doi: 10.1039/d2tb02661a Nano. 2022;16(10):15959-15976.

Volume 1 Issue 1 (2024) 51 doi: 10.36922/imo.2527